´ó·¢²ÊƱƽ̨

important

Note: ´ó·¢²ÊƱƽ̨’s new Course Catalogue will replace the eCalendar. The Course Catalogue is expected to go live the week of April 22nd. When the new site is published, "mcgill.ca/study" will be redirected to the new Course Catalogue website.

Course information on this site is not reflective of offerings for the 2025–2026 academic year. Some irregularities may occur as we move operations to the incoming Course Catalogue.

EPIB 654 Pharmacoepidemiology 4 (2 credits)

Offered by: Epidemiology and Biostatistics (Faculty of Medicine and Health Sciences)

Administered by: Graduate Studies

Overview

Epidemiology & Biostatistics : The utility of epidemiological techniques for the assessment of drug benefits after their marketing is presented. The course is composed of four parts: (i) methodology of Phase IV studies (efficacy and effectiveness studies); (ii) measurement of quality of life; (iii) evaluation of the economic impact of drugs; (iv) assessment of the effects of drugs and vaccines on the public health system.

Terms: Summer 2025

Instructors: Caro, Jaime (Summer)

  • Offered only in Summer term.

  • Prerequisite(s): EPIB 601 and EPIB 607 or permission of instructor.

  • Due to the intensive nature of this course, the standard add/drop and withdrawal deadlines do not apply. Add/drop is the first lecture day and withdrawal is the second lecture day.

Back to top